Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%

Conditions

• Open-Angle Glaucoma
• Ocular Hypertension

Interventions

• DRUG: Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension
• DRUG: Brinzolamide ophthalmic suspension, 1%
• DRUG: Brimonidine tartrate ophthalmic solution, 0.2%

Sponsor

Alcon Research